Lavipharm (Greece) Performance
| LAVI Stock | EUR 1.41 0.01 0.70% |
On a scale of 0 to 100, Lavipharm holds a performance score of 24. The company secures a Beta (Market Risk) of -0.0619, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Lavipharm are expected to decrease at a much lower rate. During the bear market, Lavipharm is likely to outperform the market. Please check Lavipharm's treynor ratio, value at risk, downside variance, as well as the relationship between the maximum drawdown and potential upside , to make a quick decision on whether Lavipharm's current price movements will revert.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Lavipharm SA are ranked lower than 24 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Lavipharm unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
| Price Earnings Ratio | 11.1429 | |
| Total Cashflows From Investing Activities | -1.9 M |
Lavipharm |
Lavipharm Relative Risk vs. Return Landscape
If you would invest 83.00 in Lavipharm SA on November 19, 2025 and sell it today you would earn a total of 58.00 from holding Lavipharm SA or generate 69.88% return on investment over 90 days. Lavipharm SA is generating 0.9285% of daily returns and assumes 2.9641% volatility on return distribution over the 90 days horizon. Simply put, 26% of stocks are less volatile than Lavipharm, and 82% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Lavipharm Target Price Odds to finish over Current Price
The tendency of Lavipharm Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.41 | 90 days | 1.41 | roughly 2.02 |
Based on a normal probability distribution, the odds of Lavipharm to move above the current price in 90 days from now is roughly 2.02 (This Lavipharm SA probability density function shows the probability of Lavipharm Stock to fall within a particular range of prices over 90 days) .
Lavipharm Price Density |
| Price |
Predictive Modules for Lavipharm
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Lavipharm SA. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Lavipharm Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Lavipharm is not an exception. The market had few large corrections towards the Lavipharm's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Lavipharm SA, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Lavipharm within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.86 | |
β | Beta against Dow Jones | -0.06 | |
σ | Overall volatility | 0.20 | |
Ir | Information ratio | 0.28 |
Lavipharm Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Lavipharm for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Lavipharm SA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Lavipharm SA may become a speculative penny stock | |
| About 67.0% of the company outstanding shares are owned by corporate insiders |
Lavipharm Fundamentals Growth
Lavipharm Stock prices reflect investors' perceptions of the future prospects and financial health of Lavipharm, and Lavipharm fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Lavipharm Stock performance.
| Return On Asset | 0.0403 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 59.98 M | |||
| Shares Outstanding | 18.29 M | |||
| Price To Earning | 12.42 X | |||
| Price To Sales | 0.17 X | |||
| Revenue | 41.37 M | |||
| EBITDA | 4.72 M | |||
| Cash And Equivalents | 1.85 M | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 40.54 M | |||
| Book Value Per Share | (0.47) X | |||
| Cash Flow From Operations | 3.82 M | |||
| Earnings Per Share | 0.04 X | |||
| Total Asset | 82 M | |||
| Retained Earnings | (181 M) | |||
| Current Asset | 21 M | |||
| Current Liabilities | 87 M | |||
About Lavipharm Performance
Assessing Lavipharm's fundamental ratios provides investors with valuable insights into Lavipharm's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Lavipharm is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Lavipharm S.A. develops, manufactures, markets, and distributes pharmaceutical, cosmetic, and consumer health products in Greece and internationally. Lavipharm S.A. was founded in 1911 and is based in Paiania, Greece. LAVIPHARM operates under Drug Manufacturers - Major classification in Greece and is traded on Athens Stock Exchange.Things to note about Lavipharm SA performance evaluation
Checking the ongoing alerts about Lavipharm for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Lavipharm SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Lavipharm SA may become a speculative penny stock | |
| About 67.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Lavipharm's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Lavipharm's stock is overvalued or undervalued compared to its peers.
- Examining Lavipharm's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Lavipharm's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Lavipharm's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Lavipharm's stock. These opinions can provide insight into Lavipharm's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Lavipharm Stock Analysis
When running Lavipharm's price analysis, check to measure Lavipharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lavipharm is operating at the current time. Most of Lavipharm's value examination focuses on studying past and present price action to predict the probability of Lavipharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lavipharm's price. Additionally, you may evaluate how the addition of Lavipharm to your portfolios can decrease your overall portfolio volatility.